Zimta Alina-Andreea, Tigu Adrian Bogdan, Braicu Cornelia, Stefan Cristina, Ionescu Calin, Berindan-Neagoe Ioana
Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Front Oncol. 2020 Apr 7;10:389. doi: 10.3389/fonc.2020.00389. eCollection 2020.
The small nucleolar RNA host genes (SNHGs) are a group of long non-coding RNAs, which are reported in many studies as being overexpressed in various cancers. With very few exceptions, the SNHGs (SNHG1, SNHG3, SNHG5, SNHG6, SNHG7, SNHG12, SNHG15, SNHG16, SNHG20) are recognized as inducing increased proliferation, cell cycle progression, invasion, and metastasis of cancer cells, which makes this class of transcripts a viable biomarker for cancer development and aggressiveness. Through our literature research, we also found that silencing of SNHGs through small interfering RNAs or short hairpin RNAs is very effective in both and experiments by lowering the aggressiveness of solid cancers. The knockdown of SNHG as a new cancer therapeutic option should be investigated more in the future.
小核仁RNA宿主基因(SNHGs)是一类长链非编码RNA,许多研究报道其在多种癌症中过表达。几乎无一例外,SNHGs(SNHG1、SNHG3、SNHG5、SNHG6、SNHG7、SNHG12、SNHG15、SNHG16、SNHG20)被认为可诱导癌细胞增殖增加、细胞周期进程加快、侵袭和转移,这使得这类转录本成为癌症发展和侵袭性的可行生物标志物。通过文献研究,我们还发现,通过小干扰RNA或短发夹RNA沉默SNHGs在体内和体外实验中均能有效降低实体癌的侵袭性。作为一种新的癌症治疗选择,未来应更多地研究敲低SNHG。